コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (CIS) chemoradiotherapy in locally advanced cervix cancer.
2 be an important prognostic tool in advanced cervix cancer.
3 hemotherapy over cisplatin alone in advanced cervix cancer.
4 microbe itself, as in Burkitt's lymphoma and cervix cancer.
5 may not have a role in assessing hypoxia in cervix cancer.
6 g chemotherapy in the patient with recurrent cervix cancer.
7 splatin was the drug of choice in metastatic cervix cancer.
8 ant treatment failure still seen in advanced cervix cancer.
9 ad head and neck tumors, and two had uterine cervix cancers.
10 d HPV45 account for approximately 20% of all cervix cancers.
11 reported that VHR is upregulated in several cervix cancer cell lines as well as in carcinomas of the
12 he inhibitors decreased the proliferation of cervix cancer cells, while growth of primary normal kera
14 e response rate and PFS duration in advanced cervix cancer compared with cisplatin alone, but at the
16 fe Questionnaire Core 30 (EORTC QLQ-C30) the cervix cancer module and chemotherapy and neuropathy sub
17 risks of stomach, female breast, and uterine cervix cancers persisted for 25 years, an apparent decre
18 is the standard of care for locally advanced cervix cancer; the optimal chemotherapy regimen is not y
19 ode identification in patients with invasive cervix cancer undergoing radical hysterectomy and pelvic
20 se I study in patients with locally advanced cervix cancer, using alternating cycles of BUdR and radi
21 VAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing
23 initiated in patients with advanced squamous cervix cancer who had received no prior chemotherapy.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。